(Q46563270)

23 December 2017

title

Failure in downregulation of intratumoral survivin expression following neoadjuvant chemoradiation in esophageal cancer (English)

1 reference

23 December 2017

0 references

3

Ute Warnecke-Eberz

1 reference

23 December 2017

Ralf Metzger

6

object named as

Ralf Metzger

1 reference

23 December 2017

author name string

Daniel Vallböhmer

1

1 reference

23 December 2017

Elmar Kuhn

2

1 reference

23 December 2017

Jan Brabender

4

1 reference

23 December 2017

Andreas C Hoffmann

5

1 reference

23 December 2017

Stephan E Baldus

7

1 reference

23 December 2017

Uta Drebber

8

1 reference

23 December 2017

Arnulf H Hoelscher

9

1 reference

23 December 2017

Paul M Schneider

10

1 reference

23 December 2017

publication date

1 June 2008

1 reference

23 December 2017

published in

Pharmacogenomics

1 reference

23 December 2017

volume

9

1 reference

23 December 2017

issue

6

1 reference

23 December 2017

page(s)

681-690

1 reference

23 December 2017

cites work

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.681

Multimodality therapy for esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.681

Current and ongoing progress in the therapy for resectable esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.681

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.681

Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.681

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.681

Structural basis for phosphoserine-proline recognition by group IV WW domains

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.681

Targeting survivin in cancer therapy: fulfilled promises and open questions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.681

Expression of IAP family proteins in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.681

Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.681

Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.681

Survivin, a potential biomarker in the development of Barrett's adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.681

[Regression of oesophageal carcinomas after neoadjuvant radiochemotherapy: criteria of the histopathological evaluation].

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.681

Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.681

High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.681

Neoadjuvant chemotherapy for epithelial ovarian cancer--role of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.681

Immunohistochemical analysis of nuclear survivin expression in esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.681

Apoptotic and proliferative indexes in esophageal cancer: Predictors of response to neoadjuvant therapy apoptosis and proliferation in esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.681

Survivin as a radioresistance factor in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.681

Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.681

Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti-IGF-IR antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.681

Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.681

Survival After Neoadjuvant Therapy Compared with Surgery Alone for Resectable Esophageal Cancer in a Population-based Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.6.681

21 January 2018

Identifiers

DOI

10.2217/14622416.9.6.681

1 reference

23 December 2017

PubMed ID

18518847

1 reference

23 December 2017